Guru Ownership Trend
Guru Analysis for Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $55.04 M.
Top institutional holders include Steven Cohen and Catherine Wood.
Institutional sentiment is currently Bullish. This is evidenced by a $47.91 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 656.2%. Conversely, Paul Tudor Jones reduced exposure by 31.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Caris Life Sciences, Inc. (CAI)
Major holders include Steven Cohen ($50.31 M), Catherine Wood ($11.03 M), Renaissance Technologies (RenTech) ($8.9 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.85 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $47.91 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CAI. The total reported sell value was $3.9 M.
Yes, 0 managers opened new positions in CAI, and 4 increased their existing holdings. The total reported buy value was $51.81 M.